ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CHRS Coherus BioSciences Inc

2.25
0.08 (3.69%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Coherus BioSciences Inc CHRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.08 3.69% 2.25 18:12:45
Open Price Low Price High Price Close Price Previous Close
2.20 2.19 2.3219 2.27 2.17
more quote information »

Recent News

Date Time Source Heading
5/01/202415:30GLOBECoherus to Report First Quarter 2024 Financial Results on..
4/24/202409:02GLOBECoherus Announces Presentation at the 2024 American Society..
4/08/202407:30GLOBECoherus Presents Preclinical Data for CHS-1000, a Novel..
3/13/202415:01GLOBECoherus BioSciences Reports Fourth Quarter, Full Year 2023..
3/05/202415:01GLOBECoherus to Report Fourth Quarter and Full Year 2023..
3/04/202405:22EDGAR2Form 8-K - Current report
3/04/202400:00GLOBECoherus Completes Divestiture of Ophthalmology Franchise
2/23/202416:33GLOBECoherus BioSciences Announces New Employment Inducement..
2/22/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202416:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/22/202415:59EDGAR2Form 8-K - Current report
2/21/202407:30GLOBECoherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and..
2/05/202407:09EDGAR2Form 8-K - Current report
2/05/202407:00GLOBECoherus Amends Term Loan Agreement with Pharmakon Advisors,..
1/23/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202407:01EDGAR2Form 8-K - Current report
1/22/202400:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
1/22/202400:15GLOBECoherus Announces Agreement to Divest Ophthalmology..
1/18/202415:05GLOBECoherus Presents Positive Phase 2 Clinical Data on..
1/09/202420:41EDGAR2Form 8-K - Current report
1/09/202420:39EDGAR2Form 8-K - Current report
1/09/202418:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202417:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202407:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
1/03/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202408:00GLOBECoherus BioSciences Management to Present at the 42nd Annual..
1/02/202407:29GLOBECoherus Announces U.S. Launch of LOQTORZI™
12/27/202308:15APSAnother Biotech Massively Outperforming Broader Equities
12/27/202305:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
12/26/202315:43DJNCoherus BioSciences Gets FDA OK for Udenyca Injector
12/26/202315:01GLOBECoherus Announces FDA Approval of UDENYCA ONBODY™, a Novel..
12/22/202316:00GLOBECoherus BioSciences Announces New Employment Inducement..
12/15/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202315:13EDGAR2Form 8-K - Current report
12/11/202307:30GLOBECoherus Announces Updated NCCN Clinical Practice Guidelines..
12/07/202316:55GLOBECoherus BioSciences Announces CFO Transition Plans
12/07/202316:16EDGAR2Form 8-K - Current report
12/06/202303:00GLOBECoherus Presents Phase 1/2 Clinical Data on Casdozokitug, a..
11/28/202310:16GLOBECoherus and Junshi Biosciences Announce Publication of..
11/27/202315:03EDGAR2Form 8-K - Current report
11/13/202305:07EDGAR2Form 8-K/A - Current report: [Amend]
11/06/202315:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202315:31EDGAR2Form 8-K - Current report
11/06/202315:07GLOBECoherus BioSciences Reports Third Quarter 2023 Financial..
11/06/202305:07EDGAR2Form 8-K/A - Current report: [Amend]
11/03/202307:30GLOBECoherus Presents Data from Next-generation Immuno-oncology..
11/02/202319:00GLOBECoherus BioSciences to Participate at Upcoming November..

Your Recent History

Delayed Upgrade Clock